Clinical Trial Update: Abiraterone Acetate Combined With Dutasteride for Metastatic Castrate Resistant Prostate Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial results for combining abiraterone acetate with dutasteride in metastatic castration-resistant prostate cancer have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Castration-resistant Prostate Cancer

Drugs mentioned

• Abiraterone acetate (Abiraterone acetate)
• DUTASTERIDE (Dutasteride)

Snippet

Sponsor: Mary-Ellen Taplin, MD | Conditions: Prostate Cancer | Phase 2 | Status: COMPLETED | Results posted: 2017-06-14